
Who We Are
Sino-American Biotechnology and Pharmaceutical Professional Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs
of any origin
who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
For more information about the San Diego chapter of SABPA, click here.
For more information about the Orange County/Los Angeles chapter of SABPA, click here.
Our Mission
- Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
- Foster professional growth, career improvement and personal development of our members;
- Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
- Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.
Our Vision
SABPA will become the most valuable professional association to our members and to our community.
Join Us
The strength of our association is derived from our members. If you are interested in exploring greater opportunities in the biotech and pharmaceutical fields, we encourage you to join us.
Please spread this message to your friends and colleagues who may be interested in joining us.
SABPA Board of Directors:
| Name |
Affiliation/Company |
Hui Cai, Chair |
HUYA Bioscience |
Paul DeRidder , Vice Chair |
Tech Coast Angels |
Hui Li, Vice Chair, President, SD |
Pfizer, Inc. |
Zhu Shen, Vice Chair |
BioForesight |
Ying Zhao, President, OC/LA |
ThorLabs, Inc. |
Sui Xiong Cai |
EpiCept Corporation |
Zhongping Chen |
UC-Irvine |
Xiangming Fang |
GenWay Biotech, Inc. |
Gen-Sheng Feng |
Burnham Institute |
Peggy Fu |
Paul Hastings |
Ming Guo |
Ascenta Therapeutics, Inc |
Rongshi Li |
Pharmaron Inc. |
Xiaoxiong Lu |
Arena Pharmaceuticals |
Chun Luo |
Accelagen |
Sofia Qiao |
Lead Therapeutics, Inc . |
Amy Smith |
Takeda San Diego |
Feng Tian |
Metabasis Therapeutics Inc. |
Jackson Wan |
Johnson & Johnson PRD |
Zhen Ping Wu |
Hutchinson MediPharm |
Yinong Xie |
Exelixis Inc. |
Peter Zhu |
Pfizer, Inc. |
|